Email not displaying properly? View email in your browser
Vertical-Talk Pharma    Nanotechnology For Lung Cancer
 Benchling Molecular Biology 2.0
 Anticancer Drug Protection
April 2017 e-Newsletter Archives    |    Advertise
News
Allergan Expands Leading Research & Development NASH Program with...
Novartis expands global collaboration with Amgen to commercialize first...
AstraZeneca's lung cancer drug Tagrisso receives full approval in the EU
 
Press Releases
Roche Diagnostics recognizes Sentara...
Lilly Announces Phase 3 MONARCH 3 Breast...
Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly...
 
Events
01 -04 MAY 2017
Pharmaceutical Regulations Summit
08 -10 MAY 2017
10th Asia-Pacific Pharma Congress
23 -24 MAY 2017
Biologistics World Korea 2017
One Step ahead
Articles
  Nanotechnology-based Inhalation Treatment for Lung Cancer
Priya Patel, Assistant Professor, Department of Pharmaceutical Sciences, Saurashtra University, Rajkot,India
From the decades drug delivery via pulmonary route become an attractive route to treat various diseases. Nanotechnology based drug delivery system for pulmonary specially polymeric, SLN, Liposomal nanoparticles are designed to targeted formulations to the specific site along...
Techno Trends
 Benchling Announces Release of Its Molecular Biology 2.0 to Power...
 Anticancer Drugs Breakthrough to Revolutionize New Medications
MECO
Projects
 TEDOR Pharma, Inc. to Expand its Manufacturing Facility in Cumberland
 Datwyler Invests More Than US$100 million in Building New US Plant
Reports
  Embracing Innovation, Driving Growth Across Healthcare Continuum - "Making in India"
medicalfair
e-Magazine  |  Subscribe  |  Unsubscribe  |  Previous Issues  |  Advisory Board  |  Editorial Calendar  |  Media Pack
www.pharmafocusasia.com – Owned by Ochre Media Pvt. Ltd.
Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 I Fax: +91 40 4961 4555